PPM1D Mutations in Circulating White Blood Cells and the Risk for Ovarian Cancer
Authors:
- Mohammad R. AkbariMAMohammad R. Akbari
- Pierre LepagePLPierre Lepage
- Barry RosenBRBarry Rosen
- John McLaughlinJMJohn McLaughlin
- Harvey RischHRHarvey Risch
- Mark MindenMMMark Minden
- Steven A. NarodSNSteven A. Narod
Open Access
- 21 November 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 106 (1) , djt323
Abstract
We compared the frequency of PPM1D mutation in the white blood cells from 1295 ovarian cancer case patients and 834 control subjects. We found a truncating mutation in 20 case patients vs 1 control subject (odds ratio [OR] = 13.07; 95% confidence interval [CI] = 1.75 to 97.55; P < .001). The 12-year mortality of the PPM1D -positive case patients was higher than that of the PPM1D -negative case patients (hazard ratio = 2.02; 95% CI = 1.21 to 3.39; P = .007). Three of the 20 PPM1D carrier case patients had a past history of breast cancer compared with 29 of 1129 noncarriers (OR = 6.69; 95% CI = 1.86 to 24.11; P = .007). The lifetime risks for breast or ovarian cancer among female first-degree relatives of PPM1D mutation carriers were not increased compared with that of case patients without mutations. These observations suggest PPM1D mutations in the mosaic state predispose women to breast and ovarian cancer in the absence of a family history of cancer.Keywords
This publication has 14 references indexed in Scilit:
- Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2JNCI: Journal of the National Cancer Institute, 2013
- Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancerNature, 2012
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencingProceedings of the National Academy of Sciences, 2011
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancerGynecologic Oncology, 2011
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersInternational Journal of Cancer, 2008
- Salpingo-oophorectomy and the Risk of Ovarian, Fallopian Tube, and Peritoneal Cancers in Women With a BRCA1 or BRCA2 MutationJAMA, 2006
- p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiationThe EMBO Journal, 2000
- Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent mannerProceedings of the National Academy of Sciences, 1997